dextroamphetamine has been researched along with Bradykinesia in 2 studies
Dextroamphetamine: The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic.
(S)-amphetamine : A 1-phenylpropan-2-amine that has S configuration.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Christine, CW | 1 |
| Marks, WJ | 1 |
| Ostrem, JL | 1 |
| Andersen, MB | 1 |
| Werge, T | 1 |
| Fink-Jensen, A | 1 |
2 other studies available for dextroamphetamine and Bradykinesia
| Article | Year |
|---|---|
Development of Parkinson's disease in patients with Narcolepsy.
Topics: Adult; Age of Onset; Antiparkinson Agents; Cataplexy; Central Nervous System Stimulants; Deep Brain | 2012 |
The acetylcholinesterase inhibitor galantamine inhibits d-amphetamine-induced psychotic-like behavior in Cebus monkeys.
Topics: Animals; Arousal; Behavior, Animal; Cebus; Cholinesterase Inhibitors; Dextroamphetamine; Dyskinesia, | 2007 |